Caitong International Asset Management Co., LTD Uro Gen Pharma Ltd. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 14 shares of URGN stock, worth $150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$150
Previous $149,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
138Shares Held
39.1MCall Options Held
9.8KPut Options Held
49.2K-
Rtw Investments, LP New York, NY3.83MShares$41.3 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$31.5 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.8 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.6 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.8 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $245M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...